Search for: "PFIZER"
Results 2121 - 2140
of 4,635
Sort by Relevance
|
Sort by Date
17 Jul 2012, 2:49 pm
D’Ambra, Counsel at Drinker Biddle & Reath LLP; Eugene “Gene” Eames, Director of Search and Data Analytics at Pfizer; Lynn Frances, Principal at E-Discovery Writer; Bill Gallivan, CEO of Digital WarRoom in Seattle; Daniel P. [read post]
17 Jul 2012, 1:57 am
The case is Dr Reddy's Laboratories (UK) Ltd and another company v Warner-Lambert Company LLC [2012] EWHC 1719 (Ch), a Patents Court, England and Wales, decision of Mr Justice Roth of 28 June in relation to a dispute which arose over atorvastatin, a popular pharma product distributed in the UK by Pfizer (Warner Lambert being part of the Pfizer group of companies: the defendant was referred to as 'Pfizer' throughout the proceedings). [read post]
16 Jul 2012, 4:55 pm
A class action injury lawsuit seeking over $600M against drug maker Pfizer Inc. was even filed by women in Canada who blame the contraception for their osteoporosis. [read post]
14 Jul 2012, 2:43 pm
The GSK settlement follows similar settlements by Pfizer in 2009 for $2.3 billion and Abbott Laboratories in May for $1.6 billion. [read post]
14 Jul 2012, 2:43 pm
The GSK settlement follows similar settlements by Pfizer in 2009 for $2.3 billion and Abbott Laboratories in May for $1.6 billion. [read post]
14 Jul 2012, 7:08 am
Statistical significance has proven a difficult concept for many judges and lawyers to understand and apply. [read post]
13 Jul 2012, 1:52 am
” Like numerous other Reglan TD lawsuits, the plaintiff in this case is blaming Wyeth, Pfizer and other pharmaceutical defendants for her injuries because she claims that they didn’t properly warn her of the dangers linked to long-term use of Reglan before she started taking the drug. [read post]
12 Jul 2012, 3:30 pm
Examples that were mentioned included Pfizer, which created the Pfizer Legal Alliance, a collaboration between 19 outside firms and the in-house counsel, and Sherwin-Williams, which cut legal costs by using creative product training methods. [read post]
11 Jul 2012, 10:02 pm
The three drugs in final tests, according to AP, are: Bapineuzumab, from Pfizer Inc. and Johnson & Johnson; Solanezumab, from Eli Lilly & Co.; and Gammagard, from Baxter International Inc. [read post]
9 Jul 2012, 4:34 am
Remember how, three years ago, Pfizer paid $2.3 billion to the Department of Justice to settle off-label claims relating to Bextra and other drugs, and Eli Lilly paid $1.4 billion for Zyprexa marketing? [read post]
8 Jul 2012, 9:13 pm
Pfizer Inc. et al. v. [read post]
8 Jul 2012, 1:58 pm
Pfizer Inc et al, U.S. [read post]
8 Jul 2012, 10:58 am
.); In re Pfizer Inc. [read post]
8 Jul 2012, 5:42 am
So now, the study that formed the basis for the original ruling against Pfizer floats aimlessly as a derelict on the sea of science. [read post]
3 Jul 2012, 11:34 am
Given what we saw with Glaxo, Pfizer and other pharma companies, it's fair to conclude there has been almost no limit to what pharma companies have done to sell their products. [read post]
3 Jul 2012, 8:53 am
In all the commentary today about London-based pharmaceutical giant GlaxoSmithKline agreeing to pay a record fine (an honor previously held by Pfizer ) of $3 billion (as well as pleading guilty to some criminal charges), ex-NY guv Eliot Spitzer's analysis made the most sense to me. [read post]
3 Jul 2012, 8:53 am
In all the commentary today about London-based pharmaceutical giant GlaxoSmithKline agreeing to pay a record fine (an honor previously held by Pfizer ) of $3 billion (as well as pleading guilty to some criminal charges), ex-NY guv Eliot Spitzer's analysis made the most sense to me. [read post]
2 Jul 2012, 10:02 am
Given what we saw with Glaxo, Pfizer and other pharma companies, it’s fair to conclude there has been almost no limit to what pharma companies have done to sell their products. [read post]
29 Jun 2012, 12:06 pm
Pfizer complains that the unsealed documents have been "cherry-picked" themselves--that they do not fairly represent Pfizer's handling of the study. [read post]
27 Jun 2012, 4:49 pm
La Administración Federal de Alimentos y Drogas de los Estados Unidos (FDA, por sus siglas en Inglés) ha aprobado el uso del calmante para el dolor de nervio Lyrica de Pfizer, Inc., para su uso en algunos tipos de pacientes que sufren lesiones de la médula espinal. [read post]
